Total Payments
$7,229
2024 Payments
$471.82
Companies
44
Transactions
607
Medicare Patients
2,099
Medicare Billing
$272,641
Payment Breakdown by Category
Food & Beverage$7,072 (97.8%)
Education$126.48 (1.7%)
Other$29.94 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,072 | 603 | 97.8% |
| Education | $126.48 | 2 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29.94 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,395 | 168 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $641.36 | 55 | $0 (2023) |
| UCB, Inc. | $590.87 | 29 | $0 (2019) |
| Allergan, Inc. | $584.04 | 98 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $427.94 | 27 | $0 (2019) |
| SK Life Science, Inc. | $320.37 | 17 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $246.75 | 29 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $235.41 | 14 | $0 (2019) |
| EISAI INC. | $212.94 | 11 | $0 (2019) |
| Amgen Inc. | $188.37 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $471.82 | 46 | ABBVIE INC. ($404.44) |
| 2023 | $618.41 | 48 | ABBVIE INC. ($343.68) |
| 2022 | $360.46 | 49 | ABBVIE INC. ($328.57) |
| 2021 | $279.30 | 38 | AbbVie Inc. ($248.31) |
| 2020 | $286.48 | 49 | Allergan, Inc. ($134.06) |
| 2019 | $1,679 | 131 | Teva Pharmaceuticals USA, Inc. ($170.30) |
| 2018 | $2,073 | 149 | Allergan Inc. ($261.64) |
| 2017 | $1,460 | 97 | Avanir Pharmaceuticals, Inc. ($271.41) |
All Payment Transactions
607 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 468 | 710 | $148,830 | $66,577 |
| 2022 | 6 | 580 | 780 | $157,108 | $73,651 |
| 2021 | 5 | 538 | 729 | $147,321 | $74,102 |
| 2020 | 7 | 513 | 647 | $133,604 | $58,312 |
Total Patients
2,099
Total Services
2,866
Medicare Billing
$272,641
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 500 | $100,640 | $47,463 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $23,455 | $10,056 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 110 | $14,960 | $7,114 | 47.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 18 | 23 | $9,775 | $1,944 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 438 | $83,220 | $43,823 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 127 | 127 | $36,830 | $16,090 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 155 | $20,860 | $9,789 | 46.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 19 | 24 | $10,200 | $2,166 | 21.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 18 | $2,398 | $1,100 | 45.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 18 | 18 | $3,600 | $683.00 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 257 | 427 | $81,130 | $43,555 | 53.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 134 | 134 | $38,860 | $17,878 | 46.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 132 | $16,632 | $9,519 | 57.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 21 | 25 | $8,579 | $2,173 | 25.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,120 | $977.01 | 46.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 236 | 354 | $67,260 | $29,102 | 43.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 114 | 114 | $33,060 | $15,122 | 45.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 64 | 69 | $12,750 | $6,126 | 48.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 53 | $6,678 | $2,636 | 39.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 23 | 28 | $6,692 | $2,447 | 36.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 15 | 15 | $5,400 | $2,151 | 39.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 14 | $1,764 | $727.62 | 41.2% |
About Alexander Komm
Alexander Komm is a Neurology healthcare provider based in Bristol, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245260157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alexander Komm has received a total of $7,229 in payments from pharmaceutical and medical device companies, with $471.82 received in 2024. These payments were reported across 607 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,072).
As a Medicare-enrolled provider, Komm has provided services to 2,099 Medicare beneficiaries, totaling 2,866 services with total Medicare billing of $272,641. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Bristol, CT
- Active Since 07/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245260157
Products in Payments
- UBRELVY (Drug) $928.96
- VRAYLAR (Drug) $506.09
- Briviact (Drug) $384.48
- NUEDEXTA (Drug) $335.73
- TROKENDI XR (Drug) $239.50
- AJOVY (Drug) $227.98
- QULIPTA (Drug) $227.62
- Fycompa (Drug) $212.94
- RYTARY (Drug) $206.46
- COPAXONE (Drug) $159.83
- INGREZZA (Drug) $157.96
- GOCOVRI (Drug) $144.17
- TECFIDERA (Drug) $132.68
- Aimovig (Biological) $131.66
- APTIOM (Drug) $121.30
- NORTHERA (Drug) $117.84
- AJOVY (Biological) $117.78
- AIMOVIG (Biological) $107.27
- Vimpat (Drug) $107.02
- Trintellix (Drug) $105.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bristol
Earl Wilson, Md, MD
Neurology — Payments: $35,176
Neurology $35,176
Shawn Nelson, Md, MD
Neurology — Payments: $22,378
Neurology $22,378
Douglas Williams, Md, MD
Neurology — Payments: $21,922
Neurology $21,922
Cara Pittari, M.d, M.D
Neurology — Payments: $9,191
Neurology $9,191
Steven Morgan, Md, MD
Neurology — Payments: $5,780
Neurology $5,780
David Brenner, Md, MD
Neurology — Payments: $727.81
Neurology $727.81